1,427.10
+2.85%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Global Health
Its shares trade on NSE under the ticker MEDANTA.NS. It has been listed since 16 November 2022. In the fiscal year to 31 March 2026, it reported revenue of ₹44.10bn and net income of ₹5.56bn. At that date it held total assets of ₹59.05bn and shareholders' equity of ₹39.62bn.
Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 16 Nov 2022
- Employees
- 9,350
- Website
- medanta.org ↗
Leadership
Pay as last reported
- Dr. Naresh TrehanChairman of the Board, Managing Director, since 2021₹183.7m
- Mr. Pankaj SahniGroup Chief Executive Officer, Whole Time Director, since 2010₹39.1m
- Mr. Yogesh GuptaChief Financial Officer
- Mr. Manoj GuptaSenior Vice President, Head - Human Resources₹10.9m
- Mr. Saurabh UpadhyaySenior Vice President, Head of Human Resources
- Mr. Rajiv SikkaChief Information Officer₹10.5m
- Mr. Rahul RanjanCompliance Officer, Company Secretary₹6.0m
- Ms. Richa SinghGeneral Counsel₹7.7m
- Dr. Sanjay GeedMedical Director - Indore Hospital/Unit₹4.3m
- Dr. Sanjeev GuptaMedical Director - Medical Administration and Clinical Operations at Medanta - the Medicity, Gurugram₹4.5m
- Mr. Bhuvander KaulChief Procurement Officer₹11.5m
- Mr. Vinodh KrishnankuttyDirector - Nursing at Medanta - the Medicity, Gurugram₹6.9m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Global Health Ltd. provides healthcare services across Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow.
- Medanta specializes in cardiac surgery, nephrology, urology, and interventional cardiology.
- The company employs 9,350 full-time employees delivering end-to-end medical services.
Weaknesses
- Medanta's services are limited to specific cities like Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow.
- The company focuses on a narrow range of medical treatments including coronary artery disease and prostate cancer.
- Global Health Ltd. has no presence outside India, restricting its market reach.
Opportunities
- Expanding into new cities such as Mumbai and Bangalore could increase market share.
- Offering telemedicine services to rural areas may improve accessibility.
- Partnering with international healthcare providers could enhance service quality.
Threats
- Competition from other healthcare providers in Delhi and Gurugram may reduce market share.
- Rising healthcare costs could decrease patient affordability.
- Regulatory changes in India might increase operational costs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.